Collaborative studies on the development of national reference standards for potency determination of H7N9 influenza vaccine

Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses

(2013) Di Liu et al.   LANCET

Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance

(2013) Yunwen Hu et al.   LANCET

Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome

(2013) Yu Chen et al.   LANCET

Genomic signature and protein sequence analysis of a novel influenza A (H7N9) virus that causes an outbreak in humans in China

(2013) Qi Liu et al.   MICROBES AND INFECTION

Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus

(2013) Rongbao Gao et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Novel Synthetic Receptor-Based Immunoassay for Influenza Vaccine Quantification

(2013) Anwar M. Hashem et al.   PLoS One

A global regulatory science agenda for vaccines

(2013) Lindsay Elmgren et al.   VACCINE

Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility

(2013) Rong Hai et al.   Nature Communications

Simultaneous quantification of the viral antigens hemagglutinin and neuraminidase in influenza vaccines by LC–MSE

(2012) Marybeth C. Creskey et al.   VACCINE

Confronting the next pandemic-Workshop on lessons learned from potency testing of pandemic (H1N1) 2009 influenza vaccines and considerations for future potency tests, Ottawa, Canada, July 27-29, 2010

(2011) Stephanie Hardy et al.   Influenza and Other Respiratory Viruses

Recombinant HA1 produced in E. coli forms functional oligomers and generates strain-specific SRID potency antibodies for pandemic influenza vaccines

(2011) Surender Khurana et al.   VACCINE

Application of deglycosylation and electrophoresis to the quantification of influenza viral hemagglutinins facilitating the production of 2009 pandemic influenza (H1N1) vaccines at multiple manufacturing sites in China

(2010) Changgui Li et al.   BIOLOGICALS

Safety and Effectiveness of a 2009 H1N1 Vaccine in Beijing

(2010) Jiang Wu et al.   NEW ENGLAND JOURNAL OF MEDICINE

An alternative method for preparation of pandemic influenza strain-specific antibody for vaccine potency determination

(2010) Falko Schmeisser et al.   VACCINE

A simple slot blot for the detection of virtually all subtypes of the influenza A viral hemagglutinins using universal antibodies targeting the fusion peptide

(2009) Changgui Li et al.   Nature Protocols

Universal antibodies and their applications to the quantitative determination of virtually all subtypes of the influenza A viral hemagglutinins

(2008) Stella Chun et al.   VACCINE

Quantitation of haemagglutinin in H5N1 influenza viruses reveals low haemagglutinin content of vaccine virus NIBRG-14 (H5N1)

(2008) Ruth Harvey et al.   VACCINE